Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species
Peter G Wells1, Yadvinder Bhuller, Connie S Chen
1Faculty of Pharmacy, Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. pg.wells@utoronto.ca
Abstract:
Developmental pathologies may result from endogenous or xenobiotic-enhanced formation of reactive oxygen species (ROS), which oxidatively damage cellular macromolecules and/or alter signal transduction. This minireview focuses upon several model drugs (phenytoin, thalidomide, methamphetamine), environmental chemicals (benzo[a]pyrene) and gamma irradiation to examine this hypothesis in vivo and in embryo culture using mouse, rat and rabbit models. Embryonic prostaglandin H synthases (PHSs) and lipoxygenases bioactivate xenobiotics to free radical intermediates that initiate ROS formation, resulting in oxidation of proteins, lipids and DNA. Oxidative DNA damage and embryopathies are reduced in PHS knockout mice, and in mice treated with PHS inhibitors, antioxidative enzymes, antioxidants and free radical trapping agents. Thalidomide causes embryonic DNA oxidation in susceptible (rabbit) but not resistant (mouse) species. Embryopathies are increased in mutant mice deficient in the antioxidative enzyme glucose-6-phosphate dehydrogenase (G6PD), or by glutathione (GSH) depletion, or inhibition of GSH peroxidase or GSH reductase. Inducible nitric oxide synthase knockout mice are partially protected. Inhibition of Ras or NF-kB pathways reduces embryopathies, implicating ROS-mediated signal transduction. Atm and p53 knockout mice deficient in DNA damage response/repair are more susceptible to xenobiotic or radiation embryopathies, suggesting a teratological role for DNA damage, consistent with enhanced susceptibility to methamphetamine in ogg1 knockout mice with deficient repair of oxidative DNA damage. Even endogenous embryonic oxidative stress carries a risk, since untreated G6PD- or ATM-deficient mice have increased embryopathies. Thus, embryonic processes regulating the balance of ROS formation, oxidative DNA damage and repair, and ROS-mediated signal transduction may be important determinants of teratological risk.
Insights
Reactive oxygen species (ROS) cause developmental pathologies by damaging cellular molecules. This review examines how xenobiotics and endogenous factors trigger ROS, leading to embryopathies, and explores protective mechanisms against this oxidative stress.
Area of Science:
- Developmental toxicology
- Oxidative stress research
- Pharmacology
Background:
- Developmental pathologies can arise from reactive oxygen species (ROS) that damage cellular components and disrupt signaling.
- Endogenous and xenobiotic factors can enhance ROS formation, contributing to embryopathies.
Purpose of the Study:
- To review the role of ROS in developmental pathologies using model drugs, environmental chemicals, and radiation.
- To examine the mechanisms of ROS generation and their impact on embryonic development in various animal models.
Main Methods:
- In vivo and embryo culture studies using mouse, rat, and rabbit models.
- Investigation of xenobiotic bioactivation by embryonic enzymes like prostaglandin H synthases (PHSs) and lipoxygenases.
- Analysis of genetic knockouts (PHS, G6PD, iNOS, Atm, p53, ogg1) and pharmacological interventions (inhibitors, antioxidants).
Main Results:
- Xenobiotics are bioactivated to free radicals initiating ROS formation, leading to protein, lipid, and DNA oxidation.
- Reduced embryopathies and DNA oxidation observed in PHS knockout mice and with PHS inhibitors, antioxidants, and free radical scavengers.
- Species-specific susceptibility to thalidomide-induced embryonic DNA oxidation noted (rabbit vs. mouse).
- Increased embryopathies in mice deficient in antioxidative enzymes (G6PD) or with depleted glutathione (GSH) pathways.
- Inhibition of Ras/NF-kB pathways and deficiency in DNA damage response/repair genes (Atm, p53, ogg1) exacerbate embryopathies.
- Endogenous oxidative stress in G6PD- or ATM-deficient mice also increases embryopathies.
Conclusions:
- Embryonic prostaglandin H synthases and lipoxygenases play a key role in bioactivating xenobiotics to initiate ROS formation.
- The balance of ROS formation, oxidative DNA damage, repair mechanisms, and ROS-mediated signaling are critical determinants of teratological risk.
- Targeting ROS-mediated pathways offers potential strategies for preventing or mitigating xenobiotic-induced embryopathies.
Related Concept Videos
Bioactivation and Tissue Toxicity
Teratogenicity
Radical Autoxidation
Oxygen Requirements and Growth Patterns
Spontaneous and Induced Mutations
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...


